234 related articles for article (PubMed ID: 9950646)
21. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
Abu Lila AS; Kizuki S; Doi Y; Suzuki T; Ishida T; Kiwada H
J Control Release; 2009 Jul; 137(1):8-14. PubMed ID: 19285528
[TBL] [Abstract][Full Text] [Related]
22. Liposomes containing cholesterol analogues of botanical origin as drug delivery systems to enhance the oral absorption of insulin.
Cui M; Wu W; Hovgaard L; Lu Y; Chen D; Qi J
Int J Pharm; 2015 Jul; 489(1-2):277-84. PubMed ID: 25957702
[TBL] [Abstract][Full Text] [Related]
23. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
[TBL] [Abstract][Full Text] [Related]
24. Effects of food intake on the mucoadhesive and gastroretentive properties of submicron-sized chitosan-coated liposomes.
Sugihara H; Yamamoto H; Kawashima Y; Takeuchi H
Chem Pharm Bull (Tokyo); 2012; 60(10):1320-3. PubMed ID: 23036972
[TBL] [Abstract][Full Text] [Related]
25. The effect of polyethylene glycol 400 on gastrointestinal transit: implications for the formulation of poorly-water soluble drugs.
Basit AW; Newton JM; Short MD; Waddington WA; Ell PJ; Lacey LF
Pharm Res; 2001 Aug; 18(8):1146-50. PubMed ID: 11587486
[TBL] [Abstract][Full Text] [Related]
26. The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems.
Sarparanta MP; Bimbo LM; Mäkilä EM; Salonen JJ; Laaksonen PH; Helariutta AM; Linder MB; Hirvonen JT; Laaksonen TJ; Santos HA; Airaksinen AJ
Biomaterials; 2012 Apr; 33(11):3353-62. PubMed ID: 22285465
[TBL] [Abstract][Full Text] [Related]
27. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
Laverman P; Carstens MG; Boerman OC; Dams ET; Oyen WJ; van Rooijen N; Corstens FH; Storm G
J Pharmacol Exp Ther; 2001 Aug; 298(2):607-12. PubMed ID: 11454922
[TBL] [Abstract][Full Text] [Related]
28. The studies of N-Octyl-N-Arginine-Chitosan coated liposome as an oral delivery system of Cyclosporine A.
Deng J; Zhang Z; Liu C; Yin L; Zhou J; Lv H
J Pharm Pharmacol; 2015 Oct; 67(10):1363-70. PubMed ID: 26105005
[TBL] [Abstract][Full Text] [Related]
29. Mushroom-brush transitional conformation of mucus-inert PEG coating improves co-delivery of oral liposome for intestinal metaplasia therapy.
Wu Y; Wang W; Yu Z; Yang K; Huang Z; Chen Z; Yan X; Hu H; Wang Z
Biomater Adv; 2022 May; 136():212798. PubMed ID: 35929326
[TBL] [Abstract][Full Text] [Related]
30. [Studies on the insulin-liposomes double-coated by chitosan and chitosan-EDTA conjugates].
Wu ZH; Ping QN; Song YM; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2004 Nov; 39(11):933-8. PubMed ID: 15696937
[TBL] [Abstract][Full Text] [Related]
31. Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition.
Furumoto K; Yokoe J; Ogawara K; Amano S; Takaguchi M; Higaki K; Kai T; Kimura T
Int J Pharm; 2007 Feb; 329(1-2):110-6. PubMed ID: 17000067
[TBL] [Abstract][Full Text] [Related]
32. Dynamic analysis of fluid distribution in the gastrointestinal tract in rats: positron emission tomography imaging after oral administration of nonabsorbable marker, [(18)F]Deoxyfluoropoly(ethylene glycol).
Takashima T; Shingaki T; Katayama Y; Hayashinaka E; Wada Y; Kataoka M; Ozaki D; Doi H; Suzuki M; Ishida S; Hatanaka K; Sugiyama Y; Akai S; Oku N; Yamashita S; Watanabe Y
Mol Pharm; 2013 Jun; 10(6):2261-9. PubMed ID: 23600944
[TBL] [Abstract][Full Text] [Related]
33. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
Wu ZH; Ping QN; Wei Y; Lai JM
Acta Pharmacol Sin; 2004 Jul; 25(7):966-72. PubMed ID: 15210073
[TBL] [Abstract][Full Text] [Related]
34. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
[TBL] [Abstract][Full Text] [Related]
35. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
36. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.
Takeuchi H; Matsui Y; Yamamoto H; Kawashima Y
J Control Release; 2003 Jan; 86(2-3):235-42. PubMed ID: 12526820
[TBL] [Abstract][Full Text] [Related]
37. Development of a Gas Empowered Drug Delivery system for peptide delivery in the small intestine.
Sadeghi AM; Avadi MR; Ejtemaimehr Sh; Abashzadeh Sh; Partoazar A; Dorkoosh F; Faghihi M; Rafiee-Tehrani M; Junginger HE
J Control Release; 2009 Feb; 134(1):11-7. PubMed ID: 19014985
[TBL] [Abstract][Full Text] [Related]
38. Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery.
Zhang S; Kucharski C; Doschak MR; Sebald W; Uludağ H
Biomaterials; 2010 Feb; 31(5):952-63. PubMed ID: 19878992
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).
Parr MJ; Masin D; Cullis PR; Bally MB
J Pharmacol Exp Ther; 1997 Mar; 280(3):1319-27. PubMed ID: 9067319
[TBL] [Abstract][Full Text] [Related]
40. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
